Modus Therapeutics AB
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin (NCT03853421) | Modus Therapeutics AB | 2019-02-06 |
Track Modus Therapeutics AB automatically
Every clearance here is in the API, with alerts when new ones post.